| # | Drug | Count |
|---|---|---|
| 0 | IFOSFAMIDE | 25 |
| 1 | IFOSFAMIDE FOR INJECTION | 25 |
| 2 | ETOPOSIDE | 24 |
| 3 | DEXAMETHASONE | 17 |
| 4 | DEXAMETHASONE 1.5 MG | 17 |
| 5 | CARBOPLATIN | 15 |
| 6 | CYCLOPHOSPHAMIDE | 13 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 9 | DOXORUBICIN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DUVELISIB | 4 | 0.0047 |
| 1 | MESNA INJECTION | 11 | 0.0013 |
| 2 | MESNA | 11 | 0.0013 |
| 3 | ETOPOSIDE PHOSPHATE | 2 | 0.0012 |
| 4 | IFOSFAMIDE FOR INJECTION | 25 | 0.0012 |
| 5 | ETOPOSIDE | 24 | 0.0003 |
| 6 | DOXORUBICIN | 12 | 0.0001 |
| 7 | DOXORUBICIN HYDROCHLORIDE | 4 | 0.0001 |
| 8 | CARBOPLATIN | 15 | 0.0001 |
| 9 | FILGRASTIM | 3 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 24 | 0.0003 |
| 1 | Alkylating Drug [EPC] | 27 | 0.0001 |
| 2 | Platinum-based Drug [EPC] | 17 | 0.0001 |
| 3 | Integrin Receptor Antagonist [EPC] | 3 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 7 | 0.0000 |
| 5 | Leukocyte Growth Factor [EPC] | 3 | 0.0000 |
| 6 | Corticosteroid [EPC] | 27 | 0.0000 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 7 | 0.0000 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 10 | 0.0000 |
| 9 | Proteasome Inhibitor [EPC] | 1 | 0.0000 |